Spyre Therapeutics (SYRE) Treasury Shares (2015 - 2025)
Spyre Therapeutics (SYRE) reported Treasury Shares of $76932.0 for Q4 2025, down 33.33% on a YoY basis from $115398.0 in Q4 2024, and down 33.33% quarter-over-quarter from $115398.0 in Q4 2024.
Spyre Therapeutics (SYRE) Treasury Shares (2015 - 2025) Analysis & Trends
Spyre Therapeutics has reported Treasury Shares for 10 years, with the latest figure at $76932.0 in Q4 2025.
- For the quarter ending Q4 2025, Treasury Shares fell 33.33% year-over-year to $76932.0; the trailing twelve-month figure through Dec 2025 stood at $76932.0 (down 33.33% YoY), and the FY2025 full-year result was $76932.0, down 33.33% from the prior year.
- Treasury Shares for Q4 2025 stood at $76932.0, down from $115398.0 in the prior quarter.
- The five-year high for Treasury Shares was $190000.0 in Q4 2021, with the low at $5660.0 in Q4 2022.
- Historically, Treasury Shares has averaged $132919.4 across 5 years, with a median of $151932.5 in 2022.
- Annual changes were most pronounced in 2022 — Treasury Shares slumped 97.02% — and 2023, when it jumped 2618.46%.
- Spyre Therapeutics' Treasury Shares stood at $190000.0 in 2021, then tumbled by 97.02% to $5660.0 in 2022, then jumped by 2618.46% to $153865.0 in 2023, then slipped by 25.0% to $115398.0 in 2024, then plunged by 33.33% to $76932.0 in 2025.
- The last three Treasury Shares figures came in at $76932.0 (Q4 2025), $115398.0 (Q4 2024), and $153865.0 (Q4 2023), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Treasury Shares (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | - |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | - |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | - |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | 1.48 Mn |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | 700,000.00 |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | - |
| 10 | Spyre Therapeutics | 6.95 Bn | 6.95 Bn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 76,932.00 |
| Dec 31, 2025 | 76,932.00 |
| Dec 31, 2024 | 115,398.00 |
| Dec 31, 2024 | 115,398.00 |
| Dec 31, 2023 | 153,865.00 |
| Dec 31, 2023 | 153,865.00 |
| Dec 31, 2022 | 5,660.00 |
| Dec 31, 2022 | 5,660.00 |
| Sep 30, 2022 | 150,000.00 |
| Sep 30, 2022 | 150,000.00 |
| Jun 30, 2022 | 181,500.00 |
| Jun 30, 2022 | 181,500.00 |
| Mar 31, 2022 | 190,000.00 |
| Mar 31, 2022 | 190,000.00 |
| Dec 31, 2021 | 190,000.00 |
| Dec 31, 2021 | 190,000.00 |
| Dec 31, 2020 | 228,200.00 |
| Dec 31, 2020 | 228,200.00 |
| Dec 31, 2018 | 6,863.00 |
| Dec 31, 2018 | 6,863.00 |